Novo Nordisk is considering investigating its GLP-1 therapies in the treatment of addictions, mirroring similar comments made by its major incretin rival Eli Lilly. …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
An international study led by the Hospital del Mar Medical Research Institute, in collaboration with researchers from the Neuropsychopharmacology Group at the University of the
Prior efforts to identify novel kidney biomarkers as risk factors for chronic kidney disease (CKD) progression have typically evaluated proteins individually, which limits their prognostic
BOSTON — An olive oil-enhanced Mediterranean diet didn’t help prevent atrial fibrillation (Afib, or AF) recurrence after ablation in the PREDIMAR randomized trial, although there